Dr Reddy's launches generic cholesterol-lowering drug in US
Mar 27 2014 , New Delhi
The company has launched Amlodipine Besylate and Atorvastatin Calcium Tablets in the US market following the approval by the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a statement.
The company's product is the generic equivalent of Pfizer Inc's Caduet tablets, it added.
The Hyderabad-based firm's Amlodipine Besylate and Atorvastatin Calcium tablets are available in bottle counts of 30 and 90, the company said.
According to IMS Health sales data, Caduet tablets brand and generics had US sales of around USD 163 million for the most recent twelve months ending in January 2014.
Dr Reddy's Laboratories shares were trading at Rs 2,594 apiece on the BSE in afternoon trade, down 1.60 per cent from its previous close.